Serology: a robust indicator of malaria transmission intensity?

Trends in Parasitology

Volumn 23, Issue 12, 2007, Pages 575-582

  Corran, Patrick ^a,b   Coleman, Paul ^a   Riley, Eleanor ^a   Drakeley, Chris ^a,c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

PARASITE ANTIBODY; PARASITE ANTIGEN;

ACCURACY; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CATALYSIS; HUMAN; HUMORAL IMMUNITY; IMMUNITY; IMMUNOFLUORESCENCE; IMMUNOGENICITY; IMMUNOLOGICAL PARAMETERS; INOCULATION; MALARIA; MALARIA FALCIPARUM; MOLECULAR MODEL; NONHUMAN; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; SAMPLE SIZE; SENSITIVITY ANALYSIS; SEROCONVERSION; SEROLOGY; SEROPREVALENCE;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BIOLOGICAL MARKERS; HUMANS; MALARIA, FALCIPARUM; MODELS, BIOLOGICAL; PLASMODIUM FALCIPARUM; PREVALENCE; PROTEIN SUBUNITS; PROTOZOAN PROTEINS; SEROEPIDEMIOLOGIC STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 36448929113     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2007.08.023     Document Type: Article

References (57)

1. Snow R.W., and Marsh K. The consequences of reducing transmission of Plasmodium falciparum in Africa. Adv. Parasitol. 52 (2002) 235-264
2. Chandramohan D., et al. Relationship between malaria endemicity and acute febrile illness mortality in children. Bull. World Health Organ. 79 (2001) 375-376
3. Reyburn H., et al. Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. J. Am. Med. Assoc. 293 (2005) 1461-1470
4. Snow R.W., et al. A preliminary continental risk map for malaria mortality among African children. Parasitol. Today 15 (1999) 99-104
5. Snow R.W., et al. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434 (2005) 214-217
6. Deloron P., and Chougnet C. Is Immunity to malaria really short-lived?. Parasitol. Today 8 (1992) 375-378
7. Craig M.H., et al. A climate-based distribution model of malaria transmission in sub-Saharan Africa. Parasitol. Today 15 (1999) 105-111
8. Hay S.I., et al. Climate variability and malaria epidemics in the highlands of East Africa. Trends Parasitol. 21 (2005) 52-53
9. Hay S.I., et al. Urbanization, malaria transmission and disease burden in Africa. Nat. Rev. Microbiol. 3 (2005) 81-90
10. Abeku T.A., et al. Malaria epidemic early warning and detection in African highlands. Trends Parasitol. 20 (2004) 400-405
11. Omumbo J.A., et al. The relationship between the Plasmodium falciparum parasite ratio in childhood and climate estimates of malaria transmission in Kenya. Malar. J. 3 (2004) 17
12. Trape J.F., et al. Assessment of the incidence and prevalence of clinical malaria in semi-immune children exposed to intense and perennial transmission. Am. J. Epidemiol. 126 (1987) 193-201
13. Snow R.W., et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 349 (1997) 1650-1654
14. Schellenberg D., et al. The changing epidemiology of malaria in Ifakara Town, southern Tanzania. Trop. Med. Int. Health 9 (2004) 68-76
15. Drakeley C., et al. An estimation of the entomological inoculation rate for Ifakara: a semi-urban area in a region of intense malaria transmission in Tanzania. Trop. Med. Int. Health 8 (2003) 767-774
16. Mbogo C.N., et al. Relationships between Plasmodium falciparum transmission by vector populations and the incidence of severe disease at nine sites on the Kenyan coast. Am. J. Trop. Med. Hyg. 52 (1995) 201-206
17. Smith T., et al. Relationships between the outcome of Plasmodium falciparum infection and the intensity of transmission in Africa. Am. J. Trop. Med. Hyg. 71 (2004) 80-86
18. Collins W.E., et al. Studies on the persistence of malarial antibody response. Am. J. Epidemiol. 87 (1968) 592-598
19. Luby J.P., et al. Persistence of malarial antibody. Findings in patients infected during the outbreak of malaria in Lake Vera, California, 1952-1953. Am. J. Trop. Med. Hyg. 16 (1967) 255-257
20. Struik S.S., and Riley E.M. Does malaria suffer from lack of memory?. Immunol. Rev. 201 (2004) 268-290
21. Voller A., and O'Neill P. Immunofluorescence method suitable for large-scale application to malaria. Bull. World Health Organ. 45 (1971) 524-529
22. Druilhe P., et al. Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection. Infect. Immun. 53 (1986) 393-397
23. Esposito F., et al. Prevalence and levels of antibodies to the circumsporozoite protein of Plasmodium falciparum in an endemic area and their relationship to resistance to malaria infection. Trans. R. Soc. Trop. Med. Hyg. 82 (1988) 827-832
24. Ramasamy R., et al. Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka. Am. J. Trop. Med. Hyg. 50 (1994) 537-547
25. De Carvalho M.E., et al. Malaria seroepidemiology: comparison between indirect fluorescent antibody test and enzyme immunoassay using bloodspot eluates. Mem. Inst. Oswaldo Cruz 87 (1992) 205-208
26. Mendis C., et al. Anti-circumsporozoite protein antibodies measure age related exposure to malaria in Kataragama, Sri Lanka. Parasite Immunol. 14 (1992) 75-86
27. Gupta S., and Snow R.W. How do bednets influence the transmissibility of Plasmodium falciparum?. Parasitol. Today 12 (1996) 89-90
28. Riley E., et al. Estimating the force of malaria infection. Parasitol. Today 12 (1996) 410-411
29. Drakeley C.J., et al. Estimating medium and long term trends in malaria transmission using serological markers of malaria exposure. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 5108-5113
30. Williams B.G., and Dye C. Maximum likelihood for parasitologists. Parasitol. Today 10 (1994) 489-493
31. Bodker R., et al. Relationship between altitude and intensity of malaria transmission in the Usambara Mountains, Tanzania. J. Med. Entomol. 40 (2003) 706-717
32. Drakeley C.J., et al. Altitude dependent and altitude independent variations in Plasmodium falciparum prevalence in North-eastern Tanzania. J. Infect. Dis. 191 (2005) 1589-1598
33. Muench H. Catalytic models in epidemiology (1959), Harvard University Press
34. Bekessy A., et al. Estimation of incidence and recovery rates of Plasmodium falciparum parasitaemia from longitudinal data. Bull. World Health Organ. 54 (1976) 685-693
35. Mei J.V., et al. Use of filter paper for the collection and analysis of human whole blood specimens. J. Nutr. 131 (2001) 1631S-1636S
36. Helfand R.F., et al. Comparative detection of measles and rubella IgM and IgG derived from filter paper blood and serum samples. J. Med. Virol. 65 (2001) 751-757
37. Orlandi-Pradines E., et al. Antibody responses to several malaria pre-erythrocytic antigens as a marker of malaria exposure among travelers. Am. J. Trop. Med. Hyg. 74 (2006) 979-985
38. Franks S., et al. Genetic diversity and antigenic polymorphism in Plasmodium falciparum: extensive serological cross-reactivity between allelic variants of merozoite surface protein 2. Infect. Immun. 71 (2003) 3485-3495
39. Hoffmann E.H., et al. Geographical patterns of allelic diversity in the Plasmodium falciparum malaria-vaccine candidate, merozoite surface protein-2. Ann. Trop. Med. Parasitol. 95 (2001) 117-132
40. Tongren J.E., et al. Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria. Infect. Immun. 74 (2006) 257-264
41. Bolad A., et al. Distinct interethnic differences in immunoglobulin G class/subclass and immunoglobulin M antibody responses to malaria antigens but not in immunoglobulin G responses to nonmalarial antigens in sympatric tribes living in West Africa. Scand. J. Immunol. 61 (2005) 380-386
42. Dolo A., et al. Difference in susceptibility to malaria between two sympatric ethnic groups in Mali. Am. J. Trop. Med. Hyg. 72 (2005) 243-248
43. Modiano D., et al. Different response to Plasmodium falciparum malaria in West African sympatric ethnic groups. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 13206-13211
44. Lim C.S., et al. Seroprevalence to the circumsporozoite protein peptide antigen of Plasmodium vivax in Korean children. Microbiol. Immunol. 49 (2005) 521-527
45. Feliciangeli M.D., et al. Chagas disease control in Venezuela: lessons for the Andean region and beyond. Trends Parasitol. 19 (2003) 44-49
46. Eggers, J.R. et al. Reconstructing historical changes in the force of infection of dengue fever in Singapore: implications for surveillance and control. Bull. World Health Organ. (in press)
47. Grenfell B.T., and Anderson R.M. The estimation of age-related rates of infection from case notifications and serological data. J. Hyg. (Lond.) 95 (1985) 419-436
48. Kirkwood B.R., and Sterne J.A.C. Chapter 28. Likelihood. Essential Medical Statistics. 2nd edn (2003), Blackwell Publishing 297-314
49. Okech B.A., et al. Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia. Infect. Immun. 72 (2004) 1557-1567
50. Thomson M.C., et al. Entomological evaluation of the Gambia's National Impregnated Bednet Programme. Ann. Trop. Med. Parasitol. 89 (1995) 229-241
51. Perraut R., et al. Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese village. J. Infect. Dis. 191 (2005) 264-271
52. Oesterholt M.J., et al. Spatial and temporal variation in malaria transmission in a low endemicity area in northern Tanzania. Malar. J. 5 (2006) 98
53. Taylor R.R., et al. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am. J. Trop. Med. Hyg. 58 (1998) 406-413
54. Polley S.D., et al. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya. Vaccine 24 (2006) 4233-4246
55. Polley S.D., et al. Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria. Vaccine 23 (2004) 718-728
56. Mwangi T.W., et al. Case definitions of clinical malaria under different transmission conditions in Kilifi District. Kenya. J. Infect. Dis. 191 (2005) 1932-1939
57. Cortes A., et al. Geographical structure of diversity and differences between symptomatic and asymptomatic infections for Plasmodium falciparum vaccine candidate AMA1. Infect. Immun. 71 (2003) 1416-1426